252 filings
8-K
XENE
Xenon Pharmaceuticals Inc
8 Mar 24
Other Events
5:27pm
10-K
2023 FY
XENE
Xenon Pharmaceuticals Inc
Annual report
29 Feb 24
4:36pm
8-K
XENE
Xenon Pharmaceuticals Inc
29 Feb 24
Xenon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
4:10pm
424B5
XENE
Xenon Pharmaceuticals Inc
30 Nov 23
Prospectus supplement for primary offering
4:18pm
8-K
XENE
Xenon Pharmaceuticals Inc
30 Nov 23
Entry into a Material Definitive Agreement
4:15pm
424B5
l1wds3x94nwgn0
29 Nov 23
Prospectus supplement for primary offering
5:05pm
8-K
0cf676k0p ay
27 Nov 23
Other Events
7:03am
8-K
o4hskqr a1el8jijvr9
9 Nov 23
Xenon Pharmaceuticals Provides Update on Partnered Program with Neurocrine Biosciences
4:06pm
8-K
0c4f7zjqmahghkil4
8 Nov 23
Xenon Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update
4:11pm
8-K
jk1q7z
9 Aug 23
Xenon Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update
4:16pm
8-K
jjhuv1df
8 Aug 23
Xenon Pharmaceuticals Expands Leadership on its Board of Directors with Appointments of Gillian M. Cannon and Justin Gover
4:07pm
8-K
d3mdrvt
2 Jun 23
Submission of Matters to a Vote of Security Holders
4:08pm
8-K
5sa1iqm3avkj6b
9 May 23
Xenon Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update
4:23pm
ARS
o30 dgcq2
27 Apr 23
Annual report to shareholders
4:20pm
8-K
wcl5nxs1dej 82i
14 Mar 23
Departure of Directors or Certain Officers
4:03pm
8-K
7fka557 hz95ajzxr
8 Mar 23
Other Events
4:25pm